Nemaura Publishes Positive Data from SugarBEAT® FDA Clinical Trial NMRD 0.044 (0.000 0.230%)

LOUGHBOROUGH, England. Nemaura Medical Inc. (NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, today published clinical data from its recently completed study intended to support a De Novo submission to the U.S Food & Drug Administration (“FDA”) for…

– $NMRD – Nemaura Continuing With the Public Offering

Detroit, Dec 18th,2018(PENNYSTOCKS.NEWS) Nemaura Medical Inc. (NASDAQ: $NMRD). Nemaura is a medical technology company in the United Kingdom, that is developing the sugarBEAT®. This is an affordable,non-invasive, and flexible Continuous Glucose Monitor (CGM) which is mostly used by people with diabetes. SugarBEAT®consists of a daily disposable adhesive skin-patch that is connected to are chargeable transmitter,…

5 Things Beginner Investors Need To Do

“I really didn’t believe that I could turn my life savings ($1,500) into a net worth of over $1 million simply by investing in stocks.” Those are the words of investing Phenom, Tim Grittani, a young investor who managed to navigate the treacherous waters of investing and day trading. The exploits of Grittani are not…

post

– $STKXF – STRIKEPOINT GOLD INC

STRIKEPOINT GOLD INC (SKP:TSX.V)(STKXF:OTCQB) IMPORTANT UPDATE – LATEST PRESS RELEASE  Top Miner  – Latest Podcast To Receive TEXT ALERTS On StrikePoint Gold TEXT ” SKP ” To 522-36 Or Complete Web Form  Website   Projects  News   Presentations  Mining News These shares have recently come alive and advanced more than 10% . We urge all serious investors to place these shares on their ACTIVE BUY LIST – StrikePoint Gold…

– $GNBT – GENEREX BIOTECHNOLOGY

GENEREX BIOTECHNOLOGY – GNBT OTCQB MEDICAL DEVICE -WOUND CARE Serious Investor Buy List – Up And Away Penny Stocks News     Biotechs Set to Surge   Stock Watch  Free Level 2 Quotes These shares have soared more than 400 % over the past 90 days and are testing their 2 year high of $20 . We expect this Biotech – Med…

– $PHBI – PHARMAGREEN BIOTECH, INC

PHARMAGREEN BIOTECH, INC – PHBI OTC Large Scale Cannabis Plantlet Supplier – DNA Modified PHBI Could Test Its $5.00 Resistance Level – A Double  – CEO Letter To Shareholders – This top biotech company is ready to ride the wave of the exploding cannabis industry providing and genetically modifying plantlets for sale to growers .…

– $HMNY – Why this business model is going to work out anyways

DETROIT, November 26, 2018 (PENNYSTOCKS.NEWS) Helios and Matheson Analytics Inc. (Nasdaq: HMNY) (“Helios”), a provider of information technology services and solutions is 92% owner of the company called MoviePass Inc. LLC, they offer nation wide premier cinema tickets subscription service to it’s subscribers. The company pays full price theater tickets for their subscribers but they…